Nandini Piramal, Chairperson of Piramal Pharma, and Arjun Juneja, COO of Mankind Pharma, delve into the future of India's pharmaceutical industry. They discuss Piramal's transformation focusing on CDMO and hospital generics, and Mankind's journey to innovation in obesity treatment. Topics include the importance of quality in manufacturing, the challenges of global regulatory scrutiny, and the need for a quality-first culture. They emphasize strategic partnerships and share ambitious visions for 2047, aiming for leadership in the evolving pharma landscape.
